(Q30425358)

30 June 2018

title

Antivirals in seasonal and pandemic influenza--future perspectives (English)

1 reference

30 June 2018

0 references

3

Rick A Bright

1 reference

30 June 2018

author name string

Michael W Wathen

series ordinal

1

1 reference

30 June 2018

Mario Barro

series ordinal

2

1 reference

30 June 2018

publication date

1 January 2013

1 reference

30 June 2018

Influenza and Other Respiratory Viruses

published in

1 reference

30 June 2018

volume

7 Suppl 1

1 reference

30 June 2018

page(s)

76-80

1 reference

30 June 2018

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

The host interactome of influenza virus presents new potential targets for antiviral drugs

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Immunomodulatory therapy for severe influenza

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

The transmissibility and control of pandemic influenza A (H1N1) virus.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

The origin and global emergence of adamantane resistant A/H3N2 influenza viruses

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Antibody recognition of a highly conserved influenza virus epitope

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Current and future antiviral therapy of severe seasonal and avian influenza

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Mechanism of action of T-705 against influenza virus

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

4 July 2018

1 reference

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.

21 January 2018

1 reference

Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina

21 January 2018

1 reference

Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study

21 January 2018

1 reference

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5978628

26 November 2018

Identifiers

DOI

10.1111/IRV.12049

1 reference

30 June 2018

PMC publication ID

5978628

1 reference

30 June 2018

PubMed publication ID

23279900

1 reference

30 June 2018